Laurus Investment Counsel Inc. Charles River Laboratories International, Inc. Transaction History

Laurus Investment Counsel Inc.

$183 Million
Q3 2024

A detailed history of Laurus Investment Counsel Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Laurus Investment Counsel Inc. holds 71,715 shares of CRL stock, worth $13.3 Million. This represents 7.74% of its overall portfolio holdings.

Number of Shares

71,715

Previous 71,715 -0.0%

Holding current value

$13.3 Million

Previous $14.8 Million 4.64%

% of portfolio

7.74%

Previous 8.72%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$164.52 - $238.84 $16,452 - $23,884	100 Added 0.14%	71,715 $17 Million
Q3 2023 Oct 13, 2023	BUY	$194.44 - $217.61 $234,689 - $262,655	1,207 Added 1.71%	71,615 $14 Million
Q2 2023 Jul 14, 2023	SELL	$183.71 - $210.25 $27,556 - $31,537	-150 Reduced 0.21%	70,408 $14.8 Million
Q1 2023 Apr 13, 2023	BUY	$191.89 - $259.92 $106,498 - $144,255	555 Added 0.79%	70,558 $14.2 Million
Q4 2022 Jan 12, 2023	SELL	$197.11 - $250.07 $123,587 - $156,793	-627 Reduced 0.89%	70,003 $0
Q3 2022 Oct 13, 2022	BUY	$182.44 - $250.54 $756,213 - $1.04 Million	4,145 Added 6.23%	70,630 $19 Million
Q2 2022 Jul 19, 2022	BUY	$204.13 - $302.4 $3.06 Million - $4.53 Million	14,985 Added 29.1%	66,485 $14.2 Million
Q1 2022 Apr 20, 2022	BUY	$255.51 - $362.11 $62,599 - $88,716	245 Added 0.48%	51,500 $14.6 Million
Q4 2021 Jan 18, 2022	BUY	$351.38 - $448.68 $119,469 - $152,551	340 Added 0.67%	51,255 $24.7 Million
Q3 2021 Oct 25, 2021	SELL	$372.64 - $458.3 $2.04 Million - $2.5 Million	-5,465 Reduced 9.69%	50,915 $26.7 Million
Q2 2021 Jul 20, 2021	SELL	$294.17 - $371.65 $808,967 - $1.02 Million	-2,750 Reduced 4.65%	56,380 $25.9 Million
Q1 2021 Jul 20, 2021	SELL	$249.67 - $299.48 $3.36 Million - $4.03 Million	-13,470 Reduced 18.55%	59,130 $17.1 Million
Q4 2020 Jul 20, 2021	SELL	$222.0 - $252.62 $3,330 - $3,789	-15 Reduced 0.02%	72,600 $18.1 Million
Q3 2020 Jul 20, 2021	BUY	$175.56 - $226.45 $38,623 - $49,819	220 Added 0.3%	72,615 $16.4 Million
Q2 2020 Jul 20, 2021	BUY	$118.84 - $189.72 $7,724 - $12,331	65 Added 0.09%	72,395 $12.6 Million
Q1 2020 Jul 20, 2021	BUY	$98.9 - $178.34 $727,409 - $1.31 Million	7,355 Added 11.32%	72,330 $9.13 Million
Q4 2019 Jul 20, 2021	BUY	$126.05 - $152.76 $6.43 Million - $7.79 Million	51,020 Added 365.6%	64,975 $9.93 Million
Q3 2019 Jul 20, 2021	BUY	$125.07 - $143.67 $999,309 - $1.15 Million	7,990 Added 133.95%	13,955 $1.85 Million
Q2 2018 Jul 20, 2021	BUY	$102.37 - $117.25 $122,844 - $140,700	1,200 Added 25.18%	5,965 $670,000
Q4 2017 Jul 20, 2021	BUY	$100.43 - $118.09 $478,548 - $562,698	4,765	4,765 $522,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurus Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurus Investment Counsel Inc. with notifications on news.

Account

Laurus Investment Counsel Inc. Charles River Laboratories International, Inc. Transaction History